Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 366

1.

Expression of proteins related to autotaxin-lysophosphatidate signaling in thyroid tumors.

Shin E, Koo JS.

J Transl Med. 2019 Aug 28;17(1):288. doi: 10.1186/s12967-019-2028-7.

2.

Immunohistochemical Analysis of Cancer Stem Cell Marker Expression in Papillary Thyroid Cancer.

Kim HM, Koo JS.

Front Endocrinol (Lausanne). 2019 Aug 2;10:523. doi: 10.3389/fendo.2019.00523. eCollection 2019.

3.

Roles of omental and bone marrow adipocytes in tumor biology.

Cha YJ, Koo JS.

Adipocyte. 2019 Dec;8(1):304-317. doi: 10.1080/21623945.2019.1643189.

PMID:
31334678
4.

Clinical and sonographic characteristics of Warthin-like variant papillary thyroid carcinomas.

Ning C, Koo JS, Kim EK, Lee S.

Med Ultrason. 2019 May 2;21(2):152-157. doi: 10.11152/mu-1870.

5.

Expression of Autotaxin⁻Lysophosphatidate Signaling-Related Proteins in Breast Cancer with Adipose Stroma.

Cha YJ, Koo JS.

Int J Mol Sci. 2019 Apr 29;20(9). pii: E2102. doi: 10.3390/ijms20092102.

6.

Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study.

Lee DW, Yim HJ, Seo YS, Na SK, Kim SY, Suh SJ, Hyun JJ, Jung SW, Jung YK, Koo JS, Kim JH, Yeon JE, Lee SW, Byun KS, Um SH.

Liver Int. 2019 Jun;39(6):1109-1119. doi: 10.1111/liv.14117. Epub 2019 May 7.

PMID:
30972935
7.

Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma.

Lee SY, Koo JS, Yang M, Cho HJ.

J Colloid Interface Sci. 2019 May 15;544:266-275. doi: 10.1016/j.jcis.2019.02.092. Epub 2019 Feb 28.

PMID:
30852352
8.

Is It Radiculopathy or Referred Pain? Buttock Pain in Spinal Stenosis Patients.

Shim DM, Kim TG, Koo JS, Kwon YH, Kim CS.

Clin Orthop Surg. 2019 Mar;11(1):89-94. doi: 10.4055/cios.2019.11.1.89. Epub 2019 Feb 18.

9.

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use.

Kang HS, Koo JS, Lee KM, Kim DB, Lee JM, Kim YJ, Yoon H, Jang HJ.

World J Gastroenterol. 2019 Feb 28;25(8):989-1001. doi: 10.3748/wjg.v25.i8.989.

10.

The Combination of MEK Inhibitor With Immunomodulatory Antibodies Targeting Programmed Death 1 and Programmed Death Ligand 1 Results in Prolonged Survival in Kras/p53-Driven Lung Cancer.

Lee JW, Zhang Y, Eoh KJ, Sharma R, Sanmamed MF, Wu J, Choi J, Park HS, Iwasaki A, Kaftan E, Chen L, Papadimitrakopoulou V, Herbst RS, Koo JS.

J Thorac Oncol. 2019 Jun;14(6):1046-1060. doi: 10.1016/j.jtho.2019.02.004. Epub 2019 Feb 13.

11.

Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck.

Lee JW, Parameswaran J, Sandoval-Schaefer T, Eoh KJ, Yang DH, Zhu F, Mehra R, Sharma R, Gaffney SG, Perry EB, Townsend JP, Serebriiskii IG, Golemis EA, Issaeva N, Yarbrough WG, Koo JS, Burtness B.

Clin Cancer Res. 2019 Jun 1;25(11):3430-3442. doi: 10.1158/1078-0432.CCR-18-0440. Epub 2019 Feb 12.

12.

[Acute Suppurative Appendicitis Diagnosed by Acute Lower Gastrointestinal Hemorrhage].

Kim DH, Lee JH, Kim D, Hwang S, Kang K, Koo JS.

Korean J Gastroenterol. 2019 Jan 25;73(1):45-49. doi: 10.4166/kjg.2019.73.1.45. Korean.

13.

Development of iron(II) sulfate nanoparticles produced by hot-melt extrusion and their therapeutic potentials for colon cancer.

Koo JS, Lee SY, Azad MOK, Kim M, Hwang SJ, Nam S, Kim S, Chae BJ, Kang WS, Cho HJ.

Int J Pharm. 2019 Mar 10;558:388-395. doi: 10.1016/j.ijpharm.2019.01.018. Epub 2019 Jan 18.

PMID:
30665001
14.

Adipokines as therapeutic targets in breast cancer treatment.

Cha YJ, Koo JS.

Expert Opin Ther Targets. 2018 Nov;22(11):941-953. doi: 10.1080/14728222.2018.1538356. Epub 2018 Oct 24. Review.

PMID:
30332900
15.

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis.

Kim DJ, Jeoun YM, Lee DW, Koo JS, Lee SW.

Intest Res. 2018 Oct;16(4):563-570. doi: 10.5217/ir.2018.00020. Epub 2018 Oct 10.

16.

Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma.

Chung JH, Kim DH, Kim YS, Son BS, Kim D, Hwang C, Shin D, Noh SG, Han JH, Kim DK, Kim JH, Koo JS, Chung HY, Yoon SH.

Cell Physiol Biochem. 2018;50(1):304-316. doi: 10.1159/000494007. Epub 2018 Oct 3.

17.

Differential Expression of Cancer-Associated Fibroblast-Related Proteins in Ductal Carcinoma in situ According to Molecular Subtype and Stromal Histology.

Lee JH, Kim HM, Koo JS.

Pathobiology. 2018;85(5-6):311-321. doi: 10.1159/000492392. Epub 2018 Sep 17.

PMID:
30223270
18.

Therapeutic Efficacies of Artemisia capillaris Extract Cream Formulation in Imiquimod-Induced Psoriasis Models.

Lee SY, Nam S, Kim S, Koo JS, Hong IK, Kim H, Han S, Kang M, Yang H, Cho HJ.

Evid Based Complement Alternat Med. 2018 Aug 19;2018:3610494. doi: 10.1155/2018/3610494. eCollection 2018.

19.

Preparation of cupric sulfate-based self-emulsifiable nanocomposites and their application to the photothermal therapy of colon adenocarcinoma.

Koo JS, Lee SY, Nam S, Azad MOK, Kim M, Kim K, Chae BJ, Kang WS, Cho HJ.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):2471-2477. doi: 10.1016/j.bbrc.2018.07.002. Epub 2018 Jul 7.

PMID:
30208513
20.

Expression of glutamine metabolism-related proteins in Hürthle cell neoplasm of thyroid: Comparison with follicular neoplasm.

Cha YJ, Jang H, Koo JS.

Histol Histopathol. 2019 Feb;34(2):167-174. doi: 10.14670/HH-18-036. Epub 2018 Sep 7.

PMID:
30191947
21.

Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.

Kim SY, Kim EK, Moon HJ, Yoon JH, Koo JS, Kim SG, Kim MJ.

Magn Reson Imaging. 2018 Dec;54:176-182. doi: 10.1016/j.mri.2018.08.017. Epub 2018 Aug 30.

PMID:
30172938
22.

External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence.

Lee BM, Chang JS, Cho YU, Park S, Park HS, Kim JY, Sohn JH, Kim GM, Koo JS, Keum KC, Suh CO, Kim YB.

Radiat Oncol J. 2018 Jun;36(2):139-146. doi: 10.3857/roj.2018.00059. Epub 2018 Jun 29.

23.
24.

Comparison on the Efficacy between Partially Covered Self-Expandable Metal Stent with Funnel-Shaped Enlarged Head versus Uncovered Self-Expandable Metal Stent for Palliation of Gastric Outlet Obstruction.

Choe JW, Hyun JJ, Lee DW, Suh SJ, Kim SY, Jung SW, Jung YK, Koo JS, Yim HJ, Lee SW.

Gastroenterol Res Pract. 2018 Apr 23;2018:4540138. doi: 10.1155/2018/4540138. eCollection 2018.

25.

Regulatory mechanisms of thiol-based redox sensors: lessons learned from structural studies on prokaryotic redox sensors.

Lee SJ, Kim DG, Lee KY, Koo JS, Lee BJ.

Arch Pharm Res. 2018 Jun;41(6):583-593. doi: 10.1007/s12272-018-1036-0. Epub 2018 May 17. Review.

PMID:
29777359
26.

Site-specific expression of amine oxidases in breast cancer metastases.

Cha YJ, Jung WH, Koo JS.

Tumour Biol. 2018 May;40(5):1010428318776822. doi: 10.1177/1010428318776822.

PMID:
29775160
27.

[The Effect of Helicobacter pylori Infection on Recurrence of Gastric Hyperplastic Polyp after Endoscopic Removal].

Kang KH, Hwang SH, Kim D, Kim DH, Kim SY, Hyun JJ, Jung SW, Koo JS, Jung YK, Yim HJ, Lee SW.

Korean J Gastroenterol. 2018 Apr 25;71(4):213-218. doi: 10.4166/kjg.2018.71.4.213. Korean.

28.

Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer.

Choi J, Kim ES, Koo JS.

Dis Markers. 2018 Feb 25;2018:9369358. doi: 10.1155/2018/9369358. eCollection 2018.

29.

Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome.

Kim SY, Choung RS, Lee SK, Choe JW, Jung SW, Hyun JJ, Koo JS, Lee SW, Shin C.

J Neurogastroenterol Motil. 2018 Apr 30;24(2):280-288. doi: 10.5056/jnm17098.

30.

Amino Acid Transporters and Glutamine Metabolism in Breast Cancer.

Cha YJ, Kim ES, Koo JS.

Int J Mol Sci. 2018 Mar 19;19(3). pii: E907. doi: 10.3390/ijms19030907. Review.

31.

Comparison of Outcomes After Mechanical Thrombectomy Alone or Combined with Intravenous Thrombolysis and Mechanical Thrombectomy for Patients with Acute Ischemic Stroke due to Large Vessel Occlusion.

Choi JH, Im SH, Lee KJ, Koo JS, Kim BS, Shin YS.

World Neurosurg. 2018 Jun;114:e165-e172. doi: 10.1016/j.wneu.2018.02.126. Epub 2018 Mar 3.

PMID:
29510288
32.

Tumor-associated macrophages and crown-like structures in adipose tissue in breast cancer.

Cha YJ, Kim ES, Koo JS.

Breast Cancer Res Treat. 2018 Jul;170(1):15-25. doi: 10.1007/s10549-018-4722-1. Epub 2018 Feb 21.

PMID:
29468486
33.

Anti-cancer activity of Bacillus amyloliquefaciens AK-0 through cyclin D1 proteasomal degradation via GSK3β-dependent phosphorylation of threonine-286.

Park GH, Song HM, Kim YS, Jeon Y, Koo JS, Jeong HJ, Jeong JB.

Pharmazie. 2017 Jun 1;72(6):348-354. doi: 10.1691/ph.2017.6199.

PMID:
29442024
34.

Differential Prognostic Impact of Strong PD-L1 Expression and 18F-FDG Uptake in Triple-negative Breast Cancer.

Choi SH, Chang JS, Koo JS, Park JW, Sohn JH, Keum KC, Suh CO, Kim YB.

Am J Clin Oncol. 2018 Feb 6. doi: 10.1097/COC.0000000000000426. [Epub ahead of print]

PMID:
29419531
35.

CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator.

Moon YW, An HJ, Koo JS, Kim GM, Han H, Park S, Kim SI, Park HS, Kim S, Kim SK, Lee SA, Hwang S, Son GW, Sohn J.

Oncotarget. 2017 Dec 21;9(2):2622-2630. doi: 10.18632/oncotarget.23519. eCollection 2018 Jan 5.

36.

Multifaceted Roles of Interleukin-6 in Adipocyte-Breast Cancer Cell Interaction.

Gyamfi J, Eom M, Koo JS, Choi J.

Transl Oncol. 2018 Apr;11(2):275-285. doi: 10.1016/j.tranon.2017.12.009. Epub 2018 Feb 3. Review.

37.

Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.

Choe JW, Jung SW, Kim SY, Hyun JJ, Jung YK, Koo JS, Yim HJ, Lee SW.

Helicobacter. 2018 Apr;23(2):e12466. doi: 10.1111/hel.12466. Epub 2018 Jan 25.

PMID:
29369454
38.

Acupuncture inhibition of methamphetamine-induced behaviors, dopamine release and hyperthermia in the nucleus accumbens: mediation of group II mGluR.

Kim NJ, Ryu Y, Lee BH, Chang S, Fan Y, Gwak YS, Yang CH, Bills KB, Steffensen SC, Koo JS, Jang EY, Kim HY.

Addict Biol. 2019 Mar;24(2):206-217. doi: 10.1111/adb.12587. Epub 2018 Jan 23.

PMID:
29363229
39.

Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer.

Sun WY, Choi J, Cha YJ, Koo JS.

Int J Mol Sci. 2017 Dec 20;18(12). pii: E2775. doi: 10.3390/ijms18122775.

40.

Effect of acupuncture on Lipopolysaccharide-induced anxiety-like behavioral changes: involvement of serotonin system in dorsal Raphe nucleus.

Yang TY, Jang EY, Ryu Y, Lee GW, Lee EB, Chang S, Lee JH, Koo JS, Yang CH, Kim HY.

BMC Complement Altern Med. 2017 Dec 11;17(1):528. doi: 10.1186/s12906-017-2039-y.

41.

Adipocyte biology in breast cancer: From silent bystander to active facilitator.

Choi J, Cha YJ, Koo JS.

Prog Lipid Res. 2018 Jan;69:11-20. doi: 10.1016/j.plipres.2017.11.002. Epub 2017 Nov 21. Review.

PMID:
29175445
42.

Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers.

Park S, Koh E, Koo JS, Kim SI, Park BW, Kim KS.

Oncotarget. 2017 Sep 15;8(47):82940-82955. doi: 10.18632/oncotarget.20937. eCollection 2017 Oct 10.

43.

Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway.

Jo SJ, Park PG, Cha HR, Ahn SG, Kim MJ, Kim H, Koo JS, Jeong J, Park JH, Dong SM, Lee JM.

Oncotarget. 2017 Aug 12;8(45):78781-78795. doi: 10.18632/oncotarget.20227. eCollection 2017 Oct 3.

44.

Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery.

Lee DW, Koo JS, Choe JW, Suh SJ, Kim SY, Hyun JJ, Jung SW, Jung YK, Yim HJ, Lee SW.

World J Gastroenterol. 2017 Sep 21;23(35):6474-6481. doi: 10.3748/wjg.v23.i35.6474.

45.

Endoscopic Treatment of Jejunal Heterotopic Gastric Mucosa that Caused Recurrent Intussusception.

Ahn KR, Koo JS, Kim HI, Kim JH, Lee JH, Kim SY, Jung SW, Lee SW.

Clin Endosc. 2017 Nov;50(6):605-608. doi: 10.5946/ce.2017.026. Epub 2017 Oct 18.

46.

Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis.

Kim HM, Lee J, Koo JS.

BMC Cancer. 2017 Oct 17;17(1):690. doi: 10.1186/s12885-017-3670-1.

47.

The value of phosphohistone H3 as a proliferation marker for evaluating invasive breast cancers: A comparative study with Ki67.

Kim JY, Jeong HS, Chung T, Kim M, Lee JH, Jung WH, Koo JS.

Oncotarget. 2017 May 10;8(39):65064-65076. doi: 10.18632/oncotarget.17775. eCollection 2017 Sep 12.

48.

Large (≥3cm) thyroid nodules with benign cytology: Can Thyroid Imaging Reporting and Data System (TIRADS) help predict false-negative cytology?

Nam SJ, Kwak JY, Moon HJ, Yoon JH, Kim EK, Koo JS.

PLoS One. 2017 Oct 12;12(10):e0186242. doi: 10.1371/journal.pone.0186242. eCollection 2017.

49.

Role of IL-1ra and Granzyme B as biomarkers in active Crohn's disease patients.

Kim TJ, Koo JS, Kim SJ, Hong SN, Kim YS, Yang SK, Kim YH.

Biomarkers. 2018 Mar;23(2):161-166. doi: 10.1080/1354750X.2017.1387933. Epub 2017 Oct 16.

PMID:
28972805
50.

Magnetic resonance metabolic profiling of estrogen receptor-positive breast cancer: correlation with currently used molecular markers.

Choi JS, Yoon D, Koo JS, Kim S, Park VY, Kim EK, Kim S, Kim MJ.

Oncotarget. 2017 Jun 28;8(38):63405-63416. doi: 10.18632/oncotarget.18822. eCollection 2017 Sep 8.

Supplemental Content

Support Center